280 related articles for article (PubMed ID: 20138023)
1. Cell-penetrating peptide exploited syndecans.
Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
[TBL] [Abstract][Full Text] [Related]
2. Contribution of syndecans to lipoplex-mediated gene delivery.
Letoha T; Kolozsi C; Ekes C; Keller-pintér A; Kusz E; Szakonyi G; Duda E; Szilák L
Eur J Pharm Sci; 2013 Jul; 49(4):550-5. PubMed ID: 23732629
[TBL] [Abstract][Full Text] [Related]
3. Molecular interplays involved in the cellular uptake of octaarginine on cell surfaces and the importance of syndecan-4 cytoplasmic V domain for the activation of protein kinase Cα.
Nakase I; Osaki K; Tanaka G; Utani A; Futaki S
Biochem Biophys Res Commun; 2014 Apr; 446(4):857-62. PubMed ID: 24632200
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
Young Kim H; Young Yum S; Jang G; Ahn DR
Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
[TBL] [Abstract][Full Text] [Related]
5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
6. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
8. Peptide-mediated protein delivery-which pathways are penetrable?
Räägel H; Säälik P; Pooga M
Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.
Skotland T; Iversen TG; Torgersen ML; Sandvig K
Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056
[TBL] [Abstract][Full Text] [Related]
10. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
11. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
12. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
[TBL] [Abstract][Full Text] [Related]
13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
14. Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.
Yang J; Tsutsumi H; Furuta T; Sakurai M; Mihara H
Org Biomol Chem; 2014 Jul; 12(26):4673-81. PubMed ID: 24867193
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9.
Hudák A; Roach M; Pusztai D; Pettkó-Szandtner A; Letoha A; Szilák L; Azzouz M; Letoha T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834552
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.
Liu J; Afshar S
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630650
[TBL] [Abstract][Full Text] [Related]
17. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
19. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides.
Kawaguchi Y; Takeuchi T; Kuwata K; Chiba J; Hatanaka Y; Nakase I; Futaki S
Bioconjug Chem; 2016 Apr; 27(4):1119-30. PubMed ID: 27019270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
